Rawlins Student Receives Solvay Scholarship

Oct. 9, 2002 -- Despite being diagnosed at an early age with cystic fibrosis (CF), an incurable genetic disease, University of Wyoming senior Cory Patterson of Rawlins has achieved academic and extracurricular honors.

Patterson is one of 20 students nationwide who have CF selected to receive a Solvay Pharmaceuticals, Inc. Creon Minimicrospheres Family Scholarship. Patterson will receive $2,000 per year for up to four years of study.

A graduate of Rawlins High School, Patterson will graduate from UW with a degree in special education. He is a member of the Kappa Delta Pi Honor Society And The Golden Key national honor society and has been listed on both the President's and Deans' honor rolls. He was an assistant coach for the Special Olympics in Laramie and now is developing a Special Olympics program in Rawlins.

Cystic fibrosis is a genetic disease affecting approximately 30,000 children and young adults in the United States. CF causes digestive and chronic lung problems that require frequent therapy.

"These students are incredible role models for others who live with CF," said Harold H. Shlevin, Solvay Pharmaceuticals president and chief executive officer. "Their courage, determination and desire for excellence are inspiring, and we are honored to enhance their educational pursuits with these scholarships."

The family scholarships are awarded to students based on academic achievement, financial need, leadership qualities and ability to serve as a role model to others with CF. Applications are available at CF treatment centers nationwide each year from March through June. Since the program's inception, the company has awarded 200 scholarships totaling more than $1.2 million.

Solvay Pharmaceuticals, Inc. (www.solvaypharmaceuticals us.com) of Marietta, Ga., is a research based pharmaceutical company, active in the therapeutic areas of cardiology, gastroenterology, mental health and women's health.

Posted on Wednesday, October 09, 2002